TY  - ADVS
AU  - Niederman,Michael S..
TI  - New concepts in the management of CAP: a focus on severe illness. Part 2 of 2, MRSA and MDR pathogens 
T2  - Periodic reports : advances in clinical interventions and research platforms,
PY  - 2022///
CY  - London
PB  - Henry Stewart Talks
KW  - Antibacterial agents
KW  - Therapeutic use
KW  - Communicable diseases
KW  - Community-acquired pneumonia
KW  - COVID-19 (Disease)
KW  - Complications
KW  - Drug resistance in microorganisms
KW  - Methicillin resistance
KW  - Pneumonia
KW  - Chemotherapy
KW  - Treatment
KW  - Staphylococcus aureus infections
KW  - Anti-Bacterial Agents
KW  - therapeutic use
KW  - Community-Acquired Infections
KW  - drug therapy
KW  - COVID-19
KW  - complications
KW  - Drug Resistance, Microbial
KW  - Methicillin-Resistant Staphylococcus aureus
KW  - epidemiology
KW  - microbiology
KW  - Pneumonia, Staphylococcal
KW  - Procalcitonin
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Community-acquired MRSA -- CA-MRSA pneumonia therapy -- Serum procalcitonin -- Steroids in severe CAP and COVID-19 -- Multidrug resistant pathogens; Access restricted to subscribers
UR  - https://hstalks.com/bs/4977/
UR  - https://hstalks.com/bs/p/1048/
ER  -